https://www.selleckchem.com/sc....reening/fda-approved
Although a relationship between schizophrenia (SCZ), antipsychotic (AP) medication, and metabolic dysregulation is now well established, the effect of adiposity is less well understood. By synthesizing findings from imaging techniques that measure adiposity, our systematic review and meta-analysis (PROSPERO CRD42020192977) aims to determine the adiposity-related effects of illness and treatment in this patient population. We searched MEDLINE, EMBASE, PsychINFO and Scopus for all relevant case-control and prospective l
Curtir
Comentario
Compartilhar
